The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine

Sandra Van der Auwera, Alexander Teumer, Johannes Hertel, Georg Homuth, Uwe Völker, Michael J. Lucht, Franziska Degenhardt, Thomas Schulze, Marcella Rietschel, Markus M. Nöthen, Ulrich John, Matthias Nauck, Hans Jörgen Grabe

Research output: Contribution to journalArticle

Abstract

Schizophrenia has a considerable genetic background. Epidemiological studies suggest an inverse clinical association between schizophrenia and migraine. However, it is unclear to what extent this inverse comorbidity can be explained by genetic mechanisms or by schizophrenia-related behavioral factors. For both disorders hypotheses of glutamate N-methyl-D-aspartate (NMDA) receptor dysfunction have been developed in the past. We hypothesized that both conditions share common genetic factors with inverse effects, primary in the glutamatergic system and genes involved in NMDA activation.Data from the population based Study of Health in Pomerania (N=3973) were used. Based on the results from the recent genome-wide association study for schizophrenia, we calculated polygenic scores (PRS) for subsets of SNPs with different p-value cutoffs and for biological sub-entities. These scores were tested for an association of distinct biological pathways with migraine.The PRS for schizophrenia was inversely associated with migraine in our sample. This association was exclusively based on the genome-wide hits and on single nucleotide polymorphisms near or within genes encoding proteins involved in glutamatergic neurotransmission. This association could be attributed to a single intronic variant rs4523957 in SRR encoding serine-racemase. Additional expression quantitative trait loci analyses of functional variants in SRR and gene-by-gene interaction analyses further supported the validity of this finding. SRR represents the rate limiting enzyme for the synthesis of D-serine, an important co-agonist of the NMDA receptor. According to our results, a decreased versus increased activation of NMDA receptors may play a role in the etiology of schizophrenia, as well as in migraine.

Original languageEnglish (US)
JournalEuropean Neuropsychopharmacology
DOIs
StateAccepted/In press - Jul 15 2015
Externally publishedYes

Fingerprint

N-Methyl-D-Aspartate Receptors
Migraine Disorders
Serine
Schizophrenia
4 alpha-glucanotransferase
Single Nucleotide Polymorphism
Genes
Quantitative Trait Loci
Genome-Wide Association Study
N-Methylaspartate
Synaptic Transmission
Comorbidity
Epidemiologic Studies
Glutamic Acid
Genome
Health
Population
Proteins

Keywords

  • D-serine
  • Migraine
  • NMDA hypo-/hyperactivation
  • Schizophrenia
  • Serine-racemase

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)
  • Biological Psychiatry
  • Neurology
  • Pharmacology

Cite this

The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine. / Van der Auwera, Sandra; Teumer, Alexander; Hertel, Johannes; Homuth, Georg; Völker, Uwe; Lucht, Michael J.; Degenhardt, Franziska; Schulze, Thomas; Rietschel, Marcella; Nöthen, Markus M.; John, Ulrich; Nauck, Matthias; Grabe, Hans Jörgen.

In: European Neuropsychopharmacology, 15.07.2015.

Research output: Contribution to journalArticle

Van der Auwera, S, Teumer, A, Hertel, J, Homuth, G, Völker, U, Lucht, MJ, Degenhardt, F, Schulze, T, Rietschel, M, Nöthen, MM, John, U, Nauck, M & Grabe, HJ 2015, 'The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine', European Neuropsychopharmacology. https://doi.org/10.1016/j.euroneuro.2016.03.019
Van der Auwera, Sandra ; Teumer, Alexander ; Hertel, Johannes ; Homuth, Georg ; Völker, Uwe ; Lucht, Michael J. ; Degenhardt, Franziska ; Schulze, Thomas ; Rietschel, Marcella ; Nöthen, Markus M. ; John, Ulrich ; Nauck, Matthias ; Grabe, Hans Jörgen. / The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine. In: European Neuropsychopharmacology. 2015.
@article{e3c753c3967d4b6f9dc35938b15e853c,
title = "The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine",
abstract = "Schizophrenia has a considerable genetic background. Epidemiological studies suggest an inverse clinical association between schizophrenia and migraine. However, it is unclear to what extent this inverse comorbidity can be explained by genetic mechanisms or by schizophrenia-related behavioral factors. For both disorders hypotheses of glutamate N-methyl-D-aspartate (NMDA) receptor dysfunction have been developed in the past. We hypothesized that both conditions share common genetic factors with inverse effects, primary in the glutamatergic system and genes involved in NMDA activation.Data from the population based Study of Health in Pomerania (N=3973) were used. Based on the results from the recent genome-wide association study for schizophrenia, we calculated polygenic scores (PRS) for subsets of SNPs with different p-value cutoffs and for biological sub-entities. These scores were tested for an association of distinct biological pathways with migraine.The PRS for schizophrenia was inversely associated with migraine in our sample. This association was exclusively based on the genome-wide hits and on single nucleotide polymorphisms near or within genes encoding proteins involved in glutamatergic neurotransmission. This association could be attributed to a single intronic variant rs4523957 in SRR encoding serine-racemase. Additional expression quantitative trait loci analyses of functional variants in SRR and gene-by-gene interaction analyses further supported the validity of this finding. SRR represents the rate limiting enzyme for the synthesis of D-serine, an important co-agonist of the NMDA receptor. According to our results, a decreased versus increased activation of NMDA receptors may play a role in the etiology of schizophrenia, as well as in migraine.",
keywords = "D-serine, Migraine, NMDA hypo-/hyperactivation, Schizophrenia, Serine-racemase",
author = "{Van der Auwera}, Sandra and Alexander Teumer and Johannes Hertel and Georg Homuth and Uwe V{\"o}lker and Lucht, {Michael J.} and Franziska Degenhardt and Thomas Schulze and Marcella Rietschel and N{\"o}then, {Markus M.} and Ulrich John and Matthias Nauck and Grabe, {Hans J{\"o}rgen}",
year = "2015",
month = "7",
day = "15",
doi = "10.1016/j.euroneuro.2016.03.019",
language = "English (US)",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",

}

TY - JOUR

T1 - The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine

AU - Van der Auwera, Sandra

AU - Teumer, Alexander

AU - Hertel, Johannes

AU - Homuth, Georg

AU - Völker, Uwe

AU - Lucht, Michael J.

AU - Degenhardt, Franziska

AU - Schulze, Thomas

AU - Rietschel, Marcella

AU - Nöthen, Markus M.

AU - John, Ulrich

AU - Nauck, Matthias

AU - Grabe, Hans Jörgen

PY - 2015/7/15

Y1 - 2015/7/15

N2 - Schizophrenia has a considerable genetic background. Epidemiological studies suggest an inverse clinical association between schizophrenia and migraine. However, it is unclear to what extent this inverse comorbidity can be explained by genetic mechanisms or by schizophrenia-related behavioral factors. For both disorders hypotheses of glutamate N-methyl-D-aspartate (NMDA) receptor dysfunction have been developed in the past. We hypothesized that both conditions share common genetic factors with inverse effects, primary in the glutamatergic system and genes involved in NMDA activation.Data from the population based Study of Health in Pomerania (N=3973) were used. Based on the results from the recent genome-wide association study for schizophrenia, we calculated polygenic scores (PRS) for subsets of SNPs with different p-value cutoffs and for biological sub-entities. These scores were tested for an association of distinct biological pathways with migraine.The PRS for schizophrenia was inversely associated with migraine in our sample. This association was exclusively based on the genome-wide hits and on single nucleotide polymorphisms near or within genes encoding proteins involved in glutamatergic neurotransmission. This association could be attributed to a single intronic variant rs4523957 in SRR encoding serine-racemase. Additional expression quantitative trait loci analyses of functional variants in SRR and gene-by-gene interaction analyses further supported the validity of this finding. SRR represents the rate limiting enzyme for the synthesis of D-serine, an important co-agonist of the NMDA receptor. According to our results, a decreased versus increased activation of NMDA receptors may play a role in the etiology of schizophrenia, as well as in migraine.

AB - Schizophrenia has a considerable genetic background. Epidemiological studies suggest an inverse clinical association between schizophrenia and migraine. However, it is unclear to what extent this inverse comorbidity can be explained by genetic mechanisms or by schizophrenia-related behavioral factors. For both disorders hypotheses of glutamate N-methyl-D-aspartate (NMDA) receptor dysfunction have been developed in the past. We hypothesized that both conditions share common genetic factors with inverse effects, primary in the glutamatergic system and genes involved in NMDA activation.Data from the population based Study of Health in Pomerania (N=3973) were used. Based on the results from the recent genome-wide association study for schizophrenia, we calculated polygenic scores (PRS) for subsets of SNPs with different p-value cutoffs and for biological sub-entities. These scores were tested for an association of distinct biological pathways with migraine.The PRS for schizophrenia was inversely associated with migraine in our sample. This association was exclusively based on the genome-wide hits and on single nucleotide polymorphisms near or within genes encoding proteins involved in glutamatergic neurotransmission. This association could be attributed to a single intronic variant rs4523957 in SRR encoding serine-racemase. Additional expression quantitative trait loci analyses of functional variants in SRR and gene-by-gene interaction analyses further supported the validity of this finding. SRR represents the rate limiting enzyme for the synthesis of D-serine, an important co-agonist of the NMDA receptor. According to our results, a decreased versus increased activation of NMDA receptors may play a role in the etiology of schizophrenia, as well as in migraine.

KW - D-serine

KW - Migraine

KW - NMDA hypo-/hyperactivation

KW - Schizophrenia

KW - Serine-racemase

UR - http://www.scopus.com/inward/record.url?scp=84979655949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979655949&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2016.03.019

DO - 10.1016/j.euroneuro.2016.03.019

M3 - Article

C2 - 27394076

AN - SCOPUS:84979655949

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

ER -